Equity Profile

TFX

Teleflex Incorporated

Health CareHealth Care Equipment$6.0B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Teleflex Incorporated (TFX) is a global provider of medical technologies that enhance the health and quality of life for patients. Operating in the Health Care Equipment sector, the company focuses on developing innovative solutions for various medical procedures, which is crucial as healthcare demands continue to grow.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, essential for long-term viability.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

TFX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

-0.76%

Avg Stock Reaction

-4.06%

Last Quarter Recap

In Q1 2026, Teleflex reported an EPS of $1.39, exceeding expectations by 14.78%. The stock reacted positively, gaining 6.86% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's recent performance and historical EPS beat rate of 88%. However, the lack of analyst estimates adds uncertainty.

Bull Case

If Teleflex continues to beat EPS estimates and shows strong revenue growth, it could lead to a significant upward movement in the stock price.

Bear Case

On the other hand, if the company fails to meet expectations or shows signs of slowing growth, it could result in a sharp decline in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's strong EPS beat rate, this figure will be crucial in determining market sentiment and stock movement.

How does Teleflex plan to address any potential revenue growth challenges?

Investors will be looking for insights on the company's strategies to sustain growth, especially in a competitive healthcare market.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Teleflex's ability to leverage its recent innovations in medical technology, which could lead to stronger-than-expected revenue growth.

Supporting Evidence

The company's historical EPS beat rate of 88% suggests it has a strong track record of exceeding expectations.

Options pricing indicates a potential move of 15.64%, suggesting that the market anticipates significant news.

Recent performance trends show resilience in the healthcare sector, which may not be fully reflected in current estimates.

Key Risk

If the EPS comes in above $1.50, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued earnings growth against the backdrop of increasing competition and market pressures.

Bull Confirmed If

An EPS of $1.50 or higher would confirm the bull case and signal strong operational performance.

Bear Confirmed If

An EPS below $1.20 would confirm the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±15.64%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant potential move for the stock, indicating heightened volatility expectations around the earnings announcement.

Options are pricing ±15.6% while TFX has averaged ±10.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

49.8%

Calls (2K)P/C Ratio: 1.31Puts (2K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Teleflex beats expectations, history suggests the stock could rise by an average of 5.5%, confirming positive investor sentiment.

In-Line / Cautious

If results are in line with expectations but management provides cautious guidance, the stock may experience muted movement.

Miss

Should the company miss expectations, history indicates a potential decline of around 6.37%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in medical technology.
2Insights into revenue growth strategies and market expansion plans.
3Management's commentary on cost management and gross margin expectations.
4Details on how the company is addressing competitive pressures in the healthcare market.
5Any guidance on future earnings and market outlook.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, essential for long-term viability.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

TFX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

-0.76%

Avg Stock Reaction

-4.06%

Last Quarter Recap

In Q1 2026, Teleflex reported an EPS of $1.39, exceeding expectations by 14.78%. The stock reacted positively, gaining 6.86% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's recent performance and historical EPS beat rate of 88%. However, the lack of analyst estimates adds uncertainty.

Bull Case

If Teleflex continues to beat EPS estimates and shows strong revenue growth, it could lead to a significant upward movement in the stock price.

Bear Case

On the other hand, if the company fails to meet expectations or shows signs of slowing growth, it could result in a sharp decline in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's strong EPS beat rate, this figure will be crucial in determining market sentiment and stock movement.

How does Teleflex plan to address any potential revenue growth challenges?

Investors will be looking for insights on the company's strategies to sustain growth, especially in a competitive healthcare market.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Teleflex's ability to leverage its recent innovations in medical technology, which could lead to stronger-than-expected revenue growth.

Supporting Evidence

The company's historical EPS beat rate of 88% suggests it has a strong track record of exceeding expectations.

Options pricing indicates a potential move of 15.64%, suggesting that the market anticipates significant news.

Recent performance trends show resilience in the healthcare sector, which may not be fully reflected in current estimates.

Key Risk

If the EPS comes in above $1.50, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued earnings growth against the backdrop of increasing competition and market pressures.

Bull Confirmed If

An EPS of $1.50 or higher would confirm the bull case and signal strong operational performance.

Bear Confirmed If

An EPS below $1.20 would confirm the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±15.64%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant potential move for the stock, indicating heightened volatility expectations around the earnings announcement.

Options are pricing ±15.6% while TFX has averaged ±10.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

49.8%

Calls (2K)P/C Ratio: 1.31Puts (2K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Teleflex beats expectations, history suggests the stock could rise by an average of 5.5%, confirming positive investor sentiment.

In-Line / Cautious

If results are in line with expectations but management provides cautious guidance, the stock may experience muted movement.

Miss

Should the company miss expectations, history indicates a potential decline of around 6.37%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in medical technology.
2Insights into revenue growth strategies and market expansion plans.
3Management's commentary on cost management and gross margin expectations.
4Details on how the company is addressing competitive pressures in the healthcare market.
5Any guidance on future earnings and market outlook.